Cationic peptides: Distribution and mechanisms of resistance

Deirdre A. Devine, Robert Hancock

Research output: Contribution to journalReview article

124 Citations (Scopus)

Abstract

Cationic antimicrobial peptides are observed throughout nature. In mammals they are observed both at epithelial surfaces and within the granules of phagocytic cells. They are an important component of innate defences, since in addition to their ability to kill microorganisms, they are able to modulate inflammatory responses. With respect to their ability to kill bacteria, it is very difficult to isolate resistant mutants. However there are a few known mechanisms of intrinsic resistance, including PhoPQ-dependent and other alterations in lipopolysaccharide structure that influence self promoted uptake, and protease-mediated resistance.

LanguageEnglish
Pages703-714
Number of pages12
JournalCurrent Pharmaceutical Design
Volume8
Issue number9
DOIs
Publication statusPublished - 22 May 2002
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Devine, Deirdre A. ; Hancock, Robert. / Cationic peptides : Distribution and mechanisms of resistance. In: Current Pharmaceutical Design. 2002 ; Vol. 8, No. 9. pp. 703-714.
@article{077a4c4e4973486a8a112c7d2984c1d1,
title = "Cationic peptides: Distribution and mechanisms of resistance",
abstract = "Cationic antimicrobial peptides are observed throughout nature. In mammals they are observed both at epithelial surfaces and within the granules of phagocytic cells. They are an important component of innate defences, since in addition to their ability to kill microorganisms, they are able to modulate inflammatory responses. With respect to their ability to kill bacteria, it is very difficult to isolate resistant mutants. However there are a few known mechanisms of intrinsic resistance, including PhoPQ-dependent and other alterations in lipopolysaccharide structure that influence self promoted uptake, and protease-mediated resistance.",
author = "Devine, {Deirdre A.} and Robert Hancock",
year = "2002",
month = "5",
day = "22",
doi = "10.2174/1381612023395501",
language = "English",
volume = "8",
pages = "703--714",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

Cationic peptides : Distribution and mechanisms of resistance. / Devine, Deirdre A.; Hancock, Robert.

In: Current Pharmaceutical Design, Vol. 8, No. 9, 22.05.2002, p. 703-714.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cationic peptides

T2 - Current Pharmaceutical Design

AU - Devine, Deirdre A.

AU - Hancock, Robert

PY - 2002/5/22

Y1 - 2002/5/22

N2 - Cationic antimicrobial peptides are observed throughout nature. In mammals they are observed both at epithelial surfaces and within the granules of phagocytic cells. They are an important component of innate defences, since in addition to their ability to kill microorganisms, they are able to modulate inflammatory responses. With respect to their ability to kill bacteria, it is very difficult to isolate resistant mutants. However there are a few known mechanisms of intrinsic resistance, including PhoPQ-dependent and other alterations in lipopolysaccharide structure that influence self promoted uptake, and protease-mediated resistance.

AB - Cationic antimicrobial peptides are observed throughout nature. In mammals they are observed both at epithelial surfaces and within the granules of phagocytic cells. They are an important component of innate defences, since in addition to their ability to kill microorganisms, they are able to modulate inflammatory responses. With respect to their ability to kill bacteria, it is very difficult to isolate resistant mutants. However there are a few known mechanisms of intrinsic resistance, including PhoPQ-dependent and other alterations in lipopolysaccharide structure that influence self promoted uptake, and protease-mediated resistance.

UR - http://www.scopus.com/inward/record.url?scp=0036252092&partnerID=8YFLogxK

U2 - 10.2174/1381612023395501

DO - 10.2174/1381612023395501

M3 - Review article

VL - 8

SP - 703

EP - 714

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 9

ER -